Where Pharma Strategy and Market Research Collide
Market research, medical affairs and commercial strategy are three of the most powerful functions within a pharmaceutical organization. Although each team has specific responsibilities, all are working toward the same goal, to provide better healthcare solutions and accelerate sustainable business growth. In today’s highly competitive pharmaceutical environment, these functions are most successful when they work together as opposed to separately. Medical affairs and commercial collaboration is how that partnership usually shows up in practice.
The pharmaceutical industry is increasingly data driven, with artificial intelligence (AI), real-world evidence (RWE), competitive intelligence, patient insights and changing healthcare regulations driving decisions. By combining scientific expertise with market intelligence and commercial planning, organisations can make better informed decisions throughout the product lifecycle, from early development thru post-launch optimisation.
The Value of Cross-Functional Collaboration
No single department holds all the information to make complex business decisions.
When market research, medical affairs and commercial strategy work together, organisations are able to:
Enhance strategic planning
Minimise business risk
Enhance product positioning
Promote market access
Improve readiness to launch
Enhance patient outcomes
You work across functions to turn individual insights into enterprise-wide business value.
Market Research, Its Role
Market research is the intelligence on which strategic planning is based throughout the product life cycle.
Market research teams are focused on:
Consumer Insights
Patients research
Intelligence competitive
Market trends etc.
Prediction
Assessing the opportunity
Their findings help organisations understand customer needs, evaluate market opportunities, and identify emerging challenges before they impact business performance.
Medical Affairs’ Role
Medical affairs is the link between the scientific evidence and the real-world healthcare practice.
Medical affairs professionals add value by:
Scientific communication
Evidence production
Participation of health professionals
Clinical Perspective
Real-world evidence
Identification of the unmet medical need
Commercial strategies are scientifically credible and, thanks to their expertise, promote better patient outcomes.
Commercial Strategy
Commercial teams transform research and science into business success.
They are responsible for:
Positioning of the product
Strategy of brand
Customer involvement
Planning launches
Portfolio management
Commercial Performance
Commercial leaders leverage insights from other functions to develop strategies that enhance market performance and long-term growth.
The Three Functions Converge
The top pharmaceutical organisations align these functions at all stages of the product lifecycle.
Advantages of collaboration:
Product development
Planning for launch
Access to markets
Competitor positioning
Customer involvement
Life cycle management
In the past organisations would work sequentially, now successful ones encourage constant communication and shared decision-making.
Better Product Launches Are Helpful
Successful product launches require the involvement of all the major business functions.
These teams are trying to help:
Validate customer requirements
Improve value propositions
Preparing for medical education
Reimbursement planning assistance
Better forecast
Watch what your competitors are doing
Planning across functions greatly improves launch readiness and commercial performance.
How to Use Artificial Intelligence to Enhance Teamwork
Artificial intelligence is enabling collaboration by bringing together many sources of information.
AI assists organisations:
Consolidate data
Track competitors
Forecast market trends
Automatic reporting
Better forecasting
Support executive decisions
AI speeds up the analysis but seasoned analysts are needed to interpret the data and advise on strategy.
Putting Patients First
When patient needs are the driving force behind decision-making, these three functions overlap and become even more powerful.
Organisations should mix:
Patient insights
Feedback from healthcare professionals
Real world evidence
Market research
Clinical experience
Commercial planning
Working with the patient in mind improves healthcare results and business performance.
Creating a Unified Decision-Making Culture
Companies that consistently outperform their competitors encourage collaboration throughout the business.
Successful companies:
Exchange information freely
Tear down organisational silos
Align business goals
Invest in integrated analytics
Promote ongoing learning
Assess collaborative performance
Collaborative culture leads to faster responses to changing healthcare markets and stronger long-term strategic planning.
Executive Pharma Insights Conference (EPIC)
The Executive Pharma Insights Conference (EPIC) gathers pharmaceutical executives, market researchers, medical affairs leaders, commercial strategists, market access professionals, healthcare professionals, regulators, data scientists and technology innovators to explore how cross-functional collaboration can lead to better business outcomes. The EPIC Conference delivers practical knowledge in market research, artificial intelligence, competitive intelligence, real-world evidence, forecasting and commercial strategy to attendees. EPIC Market Research & Insights is a collaborative platform for professionals to share best practices, discuss successful case studies and develop practical frameworks to improve collaboration between research, medical and commercial functions. The Pharma Insights Conference provides valuable networking opportunities for organisations seeking to improve strategic alignment, accelerate innovation and enhance decision making across the pharmaceutical enterprise.
With the continued adoption of artificial intelligence, advanced analytics, real-world evidence and patient-centered healthcare within the pharmaceutical industry, collaboration between market research, medical affairs and commercial strategy will be even more important. Those organisations that are successful in combining these functions will be better positioned to anticipate market changes, strengthen product launches, improve access to market and create sustainable competitive advantages.
The future of pharmaceutical success is not simply about generating valuable insights, it’s about making those insights flow seamlessly across each and every business function so that faster, smarter and more effective decisions can be made.